Prodromal Parkinson's disease--using REM sleep behavior disorder as a window

Area of Science:

• Neurology
• Sleep Medicine
• Neurodegenerative Diseases

Background:

• REM sleep behavior disorder (RBD) involves acting out dreams due to loss of REM atonia.
• Idiopathic RBD is a significant prodromal marker for Parkinson's disease (PD) and synucleinopathies.
• Prospective studies indicate up to an 80% risk of developing neurodegenerative synucleinopathy in idiopathic RBD patients.

Purpose of the Study:

• To discuss the implications of RBD as a prodromal marker for synucleinopathies.
• To highlight the potential of RBD patients for early neuroprotective therapy trials.
• To explore the utility of RBD in identifying other PD prodromal predictors and studying disease epidemiology.

Main Methods:

• Review of prospective studies establishing the link between idiopathic RBD and synucleinopathy development.
• Analysis of the implications for understanding and treating early-stage neurodegenerative diseases.
• Discussion of the value of observing RBD patients transitioning to synucleinopathy.

Main Results:

• Idiopathic RBD is a powerful predictor of Parkinson's disease and synucleinopathies.
• RBD patients present a unique opportunity for early intervention and therapeutic research.
• Studying RBD aids in understanding the epidemiology and early mechanisms of PD and dementia with Lewy bodies.

Conclusions:

• Idiopathic RBD serves as a critical early indicator for synucleinopathies, including Parkinson's disease.
• RBD offers a valuable window for preclinical research, therapeutic development, and epidemiological studies.
• Prospective observation of RBD progression provides unprecedented insights into the evolution of neurodegenerative diseases.